Cargando…
Long-term Efficacy and Safety of Erenumab: Results From 64 Weeks of the LIBERTY Study
OBJECTIVE: To report the efficacy and safety of erenumab among patients with episodic migraine (EM) who were unsuccessful on 2 to 4 preventive treatments observed at week 64 of the open-label extension phase (OLEP) of A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205467/ https://www.ncbi.nlm.nih.gov/pubmed/33910942 http://dx.doi.org/10.1212/WNL.0000000000012029 |